• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    New compound and its use as a material for the transport of holes. The present invention provides novel triazatruxene derivatives which are useful as void transport materials (htm), particularly, in optoelectronic devices. The usefulness of the new compounds was confirmed in solid state sensitized solar cells based on organic-inorganic perovskites used as light scavengers. The devices achieved high energy conversion efficiencies. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2575511A1
    申请号:ES201431776
    申请日:2014-11-28
    公开日:2016-06-29
    发明作者:Shahzada Ahmad；Francisco Javier RAMOS；Samrana KAZIM；Manuel Doblaré Castellano；Mohammad Khaja Nazeeruddin；Michael Graetzel；Kasparas RAKSTYS
    申请人:Abengoa Research SL；
    IPC主号:
    专利说明:

        Description NEW COMPOUND AND ITS USE AS A HOLLOW TRANSPORTATION MATERIAL Technical Field 5 The present invention relates to new compounds, methods of preparation of the compounds, methods and uses of the compounds as material for transporting holes in optoelectronic and / or electrochemical devices which comprise the compounds, and production methods of optoelectronic and / or electrochemical devices.  Background of the invention and underlying problem of the invention The conversion of solar energy into electric current using third-generation thin film photovoltaic (PV) materials has been extensively investigated over the past two decades.  The 15 PV interleaved / monolithic devices, consisting of a mesoporous photo-anode with an organic / inorganic light collector, a conductor of solid-state recesses / redox electrolyte and a counter electrode, have gained great interest due to the ease of manufacturing , flexibility in the selection of materials and profitable production (Grätzel, Acc.  Chem  Beef.  2009, 42, 1788-1798; Hagfeldt et al. Chem  Rev.  2010, 110, 6595-6663).  Recently, voluminous layers of tin-based organometallic halide perovskite (CsSnX3, Chung et al. Nature  2012, 485, 486-489) or lead (CH3NH3PbX3, Kojima et al. J.  A.M.  Chem  Soc.  2009, 131, 6050-6051; Etgar et al. J.  A.M.  Chem  Soc.  2012, 134, 17396-17399; Kim et al. , Sci.  Rep.  2012, 2, 591: 1-7; Lee et al. , Science 2012, 338, 643-647) as a semiconductor pigment for light collection, generating high energy conversion efficiencies ().  In the solid state device with the highest performance today, Spiro-OMeTAD doped 25 (2,2 ', 7,7'-tetrakis (N, N-di-p-methoxyphenylamin) -9,9-spirobifluorene), It is used as a material for transporting holes (HTM) to transport holes from the working electrode, formed by the semiconductor and the light sensor, to the cathode, thus closing the electrical circuit of the operating cell.  The relatively low energy conversion efficiency of solid-state devices has often been attributed to the low mobility of the gaps in the Spiro-OMeTAD, which causes losses of interfacial recombination two orders of magnitude 30 higher in liquid solar cells sensitized with dye (DSCC).  An attempt has been made to find an alternative organic HTM that has superior mobility of charge carriers and that matches the HOMO level (higher orbital molecular energy occupied) to replace the Spiro-OMeTAD.  In most cases, it is difficult to compete with yields equivalent to Spiro-OMeTAD-based devices, generally due to incomplete pore filling.  35 The ideal conditions that the HTM must meet to offer good PV performance are sufficient mobility of the gaps, thermal stability and UV (ultra violet), and a HOMO energy level well adjusted to semiconductor light absorbers.  Poly [N-9-heptadecanyl-2,7-carbazol-alt-3,6-bis- (thiophen-5-yl) -2,5-dioctyl-2,5-dihydropyrrolo [3,4-] has been introduced pyrrol-1,4-dione] (PCBTDPP) as HTM in perovskite-based cells.  These 40 devices were prepared in a configuration using mp-TiO2 / CH3NH3PbBr3 / PCBTDPP / Mesoporous Au (mp).  CH3NH3PbBr3 cells showed an energy conversion efficiency of 3.0% with open circuit voltage (vca) of 1.15 eV.  Poly (3-hexylthiophene), poly- [2,1,3-benzothiadiazol-4,7-diyl [4,4-bis (2-ethylhexyl) -4H-cyclopenta [2,1-b: 3,4b were used] ] dithiophene-2,6-diyl]] (PCPDTBT), poly - [[9- (1-octylnonyl) -9H-carbazol-2,7-diyl] -2,5-thiophenediyl-2,1,3-benzothiadiazole -4,7-diyl-2,5-thiophenediyl] (PCDTBT) and poly (triarylamine) (PTAA) as HTM together with 45 perovskites (CH3NH3PbI3) as light collectors.  Due to its polymeric nature, it has long chains, so it will generate defects and a low reproducibility of the device.  In addition, polymers are known for their instability under the low vacuum conditions that occur after the step of depositing a cathode.  In these devices, the low filling factor (FF) could be due to a compensation between the series resistance and the shunt resistance.  Therefore, an increase in the FF can be envisaged by manufacturing thin layers free of perovskite pores and taking advantage of synergy with the new HTMs having a relatively low series resistance.  Due to the highly conductive nature of perovskite, a thick layer of HTM is required to avoid pores.  On the other hand, this thicker HTM coating layer increases the resistance in series due to its less conductive nature.   In summary, it is an object of the invention to provide an HTM that is readily obtainable, is cost effective and produces solar cells that have good energy conversion efficiency in a solid state configuration.  HTM that is free of additives or dopants is also essential for long-term stability.  The present invention addresses the problems described above.  Summary of the Invention Surprisingly, the present inventors have identified new candidates for compounds that are useful as HTM for optoelectronic and / or electrochemical devices such as solid-state solar cells.  In one aspect, the present invention provides compounds comprising the following structure   of formula (I): (I) in which R1 is selected from substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl, and in which R2-R5 is independently selected from H, and alkyl, alkenyl , substituted or unsubstituted alkynyl, aryl and substituents of the following formulas (II), (III) and (IV), (II) (III) (IV) 10 in which A is selected from O, S or Se and other electron donor element, and R1, R2 and R3 are independently selected from alkyl, alkenyl, alkynyl, aryl; wherein any one of said alkyl, alkenyl and alkynyl may be linear, branched or cyclic.  In one aspect, the present invention provides soluble derivatives of triazatruxene and / or 10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c] carbazole.  In one aspect, the present invention provides soluble compounds selected from 5,10,15-trihexyl-3,8,13-trimethoxy-10,15-dihydro-5H-diindole [3,2-a: 3 ', 2' -c] carbazol (HMDI) and 5,10,15-tris (4- (hexyloxy) phenyl) -10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c] carbazole ( HPDI).  In one aspect, the present invention provides an optoelectronic and / or electrochemical device comprising a compound of the present invention.  In one aspect, the present invention provides an optoelectronic and / or electrochemical device comprising soluble derivatives of triazatruxene and / or 10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole  In one aspect, the present invention provides solar cells, in particular, perovskite-based solar cells comprising a compound of the invention.  In one aspect, the present invention provides the use of the compounds of the invention as HTM.  In one aspect, the present invention provides the use of the compounds of the invention as HTM in a solar cell, in particular, a solar cell based on perovskites.  In one aspect, the present invention provides the use of the compounds of the invention as HTM in a solar cell where the HTM lacks dopants.  In one aspect, the present invention provides the use of the compounds of the invention as HTM 30 in a solar cell where the HTM comprises less than 20% molar dopant.  In one aspect, the present invention comprises a method of providing an HTM, a method comprising the step of providing the compounds of the present invention.  In one aspect, the present invention provides a process of producing a solar cell comprising the steps of applying a plurality of layers comprising at least one HTM and other layers as necessary to provide said solar cell, wherein said layer of void transport comprises a compound selected from the compounds of the present invention.  In one aspect, the present invention provides a process of producing a solar cell comprising the steps of applying a plurality of layers comprising an organic-inorganic perovskite layer, a gap transport layer and a conductive current supply layer, wherein said void transport layer comprises an HTM comprising a compound selected from the compounds of the invention.  In one aspect, the present invention provides a method of preparing the compounds of the invention, a method comprising the steps of: providing triazatruxen and replacing its hydrogens to provide the compounds of the invention.  Further, in this document and in the appended claims, additional aspects and preferred embodiments of the invention are defined.  Other features and additional advantages of the invention R1R1R1NNNR5R4R3R2R2R3R4R5R2R3R4R5AR1R2NR1R3R2SiR1   they will become apparent to the person skilled in the art from the description of the preferred embodiments offered below.  The new compounds of the invention provide several important advantages.  The new compounds can be processed in solution and can be applied to easily coat by various techniques, methods such as dip coating, centrifugation or spraying, or they can be printed.  The new compounds have a good solubility in non-polar organic solvents, which allows the use of a wide selection of solvents for the preparation of the devices containing the compounds.  They are easy to synthesize, thermally stable up to 350 ° C and transparent in the visible part of the solar spectrum.  It has been observed that these new compounds have good transport properties of 10 (hollow) charges in their original form, which results in better PV properties.  Interestingly, devices that contain non-doped HTM generally have better performance or at least similar to doped HTM.  The performance of the devices was better than that obtained with the material selected from the prior art, Spiro-OMeTAD (without doping).   BRIEF DESCRIPTION OF THE FIGURES Figure 1 is a scheme illustrating the synthesis of the illustrative compounds according to preferred embodiments of the invention.  Figure 2 shows the J-V characteristics of a solar cell containing HTM HMDI 20 and HPDI compounds according to embodiments of the invention as shown in Example 1.  Figure 3 shows conversion efficiencies of incident photon into electron (IPCE) for a compound (HMDI and HPDI) according to an embodiment of the invention as a carrier of holes in perovskite mesoscopic solar cells.  Figure 4 shows cyclic voltamperograms of compounds according to embodiments of the invention, called HMDI and HPDI molecules, established in a three electrode cell.  Figure 5 shows UV-Vis absorption spectra of exemplary HMDI and HPDI molecules in chlorobenzene.  Figure 6 shows a thermogravimetric analysis of illustrative compounds HMDI and HPDI.  It can be seen that the compounds are stable up to temperatures of approximately 350 ° C.  Figures 7 and 8 show illustrative structures of optoelectronic and / or electrochemical devices of the invention.  Figure 9 A and B shows various illustrative compounds according to preferred embodiments of the invention.   DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In one aspect, the present invention provides new compounds of formula (I).  These compounds are preferably derivatives of 10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c] carbazole (compound (1) of Figure 1).  For the purpose of the present specification, the common name of triazatruxen is used as the equivalent of 40 10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole.  For the purpose of the present specification, the term "comprises" and its various grammatical forms such as "comprising", etc.  It means "includes, among others".  It is not intended to mean "consists only of".  In said compounds, the R1 substituent is preferably selected from substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl.  Any one or more of said alkyl, alkenyl and alkynyl may be linear, branched or cyclic.  In one embodiment, R1 preferably comprises, in total, (including optional substituents of said alkyl, alkenyl, alkynyl and aryl) of 1 to 20 carbons and 0 to 10 heteroatoms, preferably, 3 to 15 carbons and 0 to 5 heteroatoms, most preferably 4 to 12 carbons and 0 to 3 heteroatoms.  The substituents of said alkyl, alkenyl, alkynyl (if substituted) may be selected from aryl, alkylaryl, alkoxyaryl, halogen and substituents of any one of formulas (II) to (IV).  The substituents of said aryl (if substituted) may be selected from alkyl, alkenyl, halogen and from substituents of any one of formulas (II) to (IV).   55 (II) (III) (IV) In said substituents of formulas (II) - (IV), R1, R2 and R3, whenever present, are independently selected from alkyl, alkenyl, alkynyl, aryl.  In said substituents of formulas (II), A is selected from O, S or Se, or other suitable electron donor element.  Preferred optional substituents of said alkyl, alkenyl, alkynyl and aryl of R1 are substituents of formula (II), more preferably substituents of formula (II), wherein A is O, and R1 is alkyl, for example, AR1R2NR1R3R2SiR1   C1-C12 alkyl, preferably C4-C10 alkyl and more preferably C6.  In the compounds of formula (I), R2-R5 can be independently selected from H, and alkyl, alkenyl, alkynyl, aryl and substituents of formula (II), (III) and (IV) substituted or unsubstituted (see above formulas), in which any one of said alkyl, alkenyl and alkynyl can be linear, branched or cyclic.  In total (including the optional substituents of said alkyl, alkenyl, alkynyl and aryl), if they are different from H, R2-R5 preferably independently comprises 1 to 20 carbons or 1 to 10 heteroatoms, preferably 1 at 15 carbons and from 1 to 5 heteroatoms, even more preferably, from 1 to 12 carbons and from 0 to 3 heteroatoms, most preferably, from 1 to 6 carbons and 1 heteroatom.  In one embodiment, R2-R5 is independently selected from H, and alkyl, alkenyl, alkynyl, aryl and substituents of formulas (II), (III) and (IV) unsubstituted (see formulas above), in which any one of said alkyl, alkenyl and alkynyl can be linear, branched or cyclic.  Preferably, R2-R5 is independently selected from H and from substituents of formula (II).  Preferably, in said substituent (II), A is O.  Preferably, R1 is independently selected from C1-C20 alkyl, preferably C1-C12 alkyl, most preferably C1-C8 alkyl.  In a preferred embodiment, one or more of R2-R5 is / are different from H and, therefore, are as defined in accordance with the embodiments of R2-R5 as defined herein.  In a preferred embodiment, said one or more substituents of R2-R5 which is / are different from H is / are alkoxy, preferably C1-C12 alkoxy, more preferably C1-C8 alkoxy.  In one embodiment of the compounds of the invention, R 1 is selected from substituted alkyl and aryl, wherein the substituents of said aryl are selected from alkyl and from substituents of formula (II), (III) or (IV), and wherein R2-R5 is independently selected from H, alkyl and substituents of formula (II), (III) or (IV).  Preferably, one or more of R2-R5 is / are different from H.  R1 preferably comprises an alkyl, for example, in the following possibilities: (i) R1 is alkyl; (ii) R1 is an alkyl substituted aryl; or (iii) R1 is an aryl substituted with a substituent of formulas (II) - (IV), preferably of formula (II), in which R1-R3 is independently selected from alkyl.  Preferably, said alkyl (of R1) is a C1-C20 alkyl, preferably a C2-C15 alkyl, most preferably a C4-C12 alkyl, in particular, an alkyl selected from C6, C8 or C10 alkyl.  Preferably, said alkyl contained in R1 is a linear alkyl.  On the other hand, in said R2-R5 substituent, if they are different from H, they also preferably comprise an alkyl, for example, in the following possibilities: (i) at least one of R2-R5 is alkyl; (ii) at least one of R2-R5 is a substituent of formulas (II) - (IV), preferably of formula (II), wherein R1-R3 is independently selected from alkyl.  Preferably, said alkyl is a C1-C12 alkyl, more preferably a C1-C8 alkyl, most preferably a C1-C6 alkyl, for example, a C1 alkyl.  In a preferred embodiment, R1 is selected from alkyl and substituted phenyl, in which the substituents 35 of said phenyl are independently selected from alkyl and from alkoxy, and R2-R5 is independently selected from H, alkyl and alkoxy, more preferably between H and alkoxy.  Preferably, one or more substituents of R2-R5 is / are different from H (and therefore are independently an alkyl or alkoxy).  Preferably, with respect to the sizes (number of carbons) of said alkyl substituents of R1 and R2-R5, including the alkyl part of the alkoxyls, the same as stated above applies.  In one embodiment, the compound of the invention is selected from compounds of the following formula (V): (V) in which R1 and R3 are as defined with respect to the present invention, preferably as defined with respect to to the preferred embodiments and embodiments specified above.  The present embodiment differs from the previous embodiments in that it is specified that R2, R4 and R5 are always H, and R3 is selected from H and from substituents that are different from H as defined in any part of the present specification.  In particular, R 3 may be selected from substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl and substituents of formulas (II), (III) and (IV) (see above formulas), which may be any one of said alkyl, alkenyl and linear, branched or cyclic alkynyl.  In a preferred embodiment, one or more of R2-R5 is / are different from H and, therefore, as defined in accordance with the embodiments of R2-R5 as defined herein.  For example, in R1R1R1NNNR3R3R3   one embodiment, R1 is selected from alkyl and substituted aryl, wherein the substituents of said aryl are selected from alkyl and from substituents of formulas (II), (III) or (IV), preferably of formula (II), and R3 is independently selects between H, alkyl and substituents of formula (II), (III) or (IV), preferably of formula (II).  In another preferred embodiment, R1 is selected from alkyl and substituted phenyl, in which the substituents of said phenyl are independently selected from alkyl and from alkoxy, and R3 is independently selected from H, alkyl and alkoxy, more preferably between H and alkoxyls.  For these embodiments, the same indicated above applies, for example, with respect to the presence and size of the alkyls.  In a preferred embodiment, the compound of the invention is selected from the compounds of the following formulas (VI) and (VII): 10 (VI) (VII) in which R6 and R7 are independently defined as the substituent R1 as defined in any part of this specification.  Preferably, R6 and R7 are independently selected from linear, branched or cyclic C1-C15 alkyls.  In a preferred embodiment, R6 and R7 are independently selected from linear, branched or cyclic C1-C12 alkyls.  In a more preferred embodiment, R6 is selected from linear and branched C4-C10 alkyls, preferably C4-C8 alkyls, and R7 is selected from linear and branched C1-C10 alkyls, preferably C1-C4 alkyls and most preferably C1 alkyls.   In a preferred embodiment, the present invention provides soluble triazatruxene derivatives.  In one embodiment, the compounds of the invention are soluble in one or more of the solvents selected from chlorobenzene, benzene, 1,2-dichlorobenzene and toluene.  Preferably, the compounds are soluble in at least toluene.  For example, the compounds are soluble in any one, in several or in all of these solvents.  In a preferred embodiment, the compounds are soluble in all of the four solvents mentioned above.  The presence of solubility is preferably determined at room temperature (25 ° C) under stirring for up to 10 minutes.  Preferably, the compounds of the invention are soluble in at least and / or more than 20 mg, preferably 50 mg of compound per ml of solvent.  More preferably, the compounds are soluble in at least and / or more than 100 mg of compound per ml of solvent, preferably 150 mg of compound 30 per ml of solvent.  In a preferred embodiment, the compounds of the invention are soluble in at least and / or more than 200 mg of compound per ml of toluene solvent.  In a preferred embodiment, the compounds of the invention are selected from 5,10,15-trihexyl-3,8,13-trimethoxy-10,15-dihydro-5H-diindole [3,2-a: 3 ', 2' -c] carbazole (compound (HMDI) in Fig.  1) and 5,10,15-tris (4-35 (hexyloxy) phenyl) -10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole (compound (HPDI) in Fig.  one).  Figures 9A and B show other illustrative compounds ((S1) - (S8)) according to the invention.  These compounds are: (S1): 5,10,15-tris (4- (hexyloxy) phenyl) -10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole; (S2): 5,10,15-tris (4-methoxyphenyl) -10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole; (S3): 5,10,15-trihexyl-3,8,13-trimethoxy-10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole; (S4): 5,10,15-trihexyl-3,8,13-tris (4-methoxyphenyl) -10,15-dihydro-5H-40 diindol [3,2-a: 3 ', 2'-c] carbazole; (S5): 5,10,15-trihexyl-N3, N3, N8, N8, N13, N13-hexaquis (4-methoxyphenyl) -10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c] carbazol-3,8,13-triamine, (S6): 4,4 ', 4' '- (5,10,15-trihexyl-10,15-dihydro-5H-diindolo [3,2 -a: 3 ', 2'-c] carbazol-3,8,13-triyl) tris (N, N-bis (4-methoxyphenyl) aniline), (S7): 5,10,15-triethyl-N3, N3, N8, N8, N13, N13-hexaquis (4-methoxyphenyl) -10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c] carbazol-3,8,13-triamine ; (S8): 4,4 ', 4' '- (5,10,15-triethyl-10,15-dihydro-5H-diindolo [3,2-a: 3', 2'-c] carbazol-3, 8,13-triyl) tris (N, N-bis (4-methoxyphenyl) aniline).  In another embodiment, the compound of the invention is selected from the compounds (S9) - (S17) below, based on the structure of the formula (VIII): NNNOR6OR6OR6R6R6R6NNNOOOR7R7R7   (VIII); wherein R11-R15 of the compounds (S9) - (S17) are selected as follows: Compound (S9): R11 = OMe, R12 = H, R13 = H, R14 = H, R15 = H.  5 Compound (S10): R11 = H, R12 = OMe, R13 = H, R14 = H, R15 = H.  Compound (S11): R11 = H, R12 = H, R13 = OMe, R14 = H, R15 = H.  Compound (S12): R11 = OMe, R12 = OMe, R13 = H, R14 = H, R15 = H.  Compound (S13): R11 = OMe, R12 = H, R13 = OMe, R14 = H, R15 = H.  Compound (S14): R11 = H, R12 = OMe, R13 = OMe, R14 = H, R15 = H.  Compound (S15): R11 = OMe, R12 = OMe, R13 = OMe, R14 = H, R15 = H.  Compound (S16): R11 = OMe, R12 = H, R13 = OMe, R14 = H, R15 = OMe.  Compound (S17): R11 = H, R12 = OMe, R13 = OMe, R14 = OMe, R15 = H.   Surprisingly, the compounds of the invention are advantageous organic HTM.  Compounds 15 are particularly advantageous as HTM in optoelectronic devices such as sensitized solar cells.  In a preferred embodiment, the invention provides an organic-inorganic perovskite-based solar cell comprising the compound of the present invention.  In the optoelectronic devices of the invention, particularly, in solar cells, the compound of the invention is preferably provided as HTM in the HTM layer of said devices.  In preferred embodiments, optoelectronic devices, in particular solar cells, are preferably flat devices when considered on a macroscopic scale.  According to a preferred embodiment, they are laminated and / or comprise and / or consist essentially of a plurality of layers.  In view of their flat configuration, the devices of the invention preferably have two opposite sides, a first side and a second side, said opposite sides preferably constituting the majority of the macroscopic surface of the device of the invention.  The compounds of the invention are particularly advantageous as HTM which acts as a transporter of holes in solar cells based on perovskites.  These devices are generally based on the architecture of "dye-sensitized solar cells", normally abbreviated as DSSC or DSC, in layers of perovskites of organometallic halides used instead of organic dyes or dyes based on metal complexes.  In one embodiment, the invention provides a solar cell 1 as illustrated in Figure 7.  The solar cell comprises two opposite sides 7, 8, which can be called (arbitrarily) a first side 7 and a second side 8.  The solar cell according to this embodiment preferably comprises a current collecting conductive layer 5, a semiconductor layer of type n 2, an inorganic organic-35 perovskite layer 3, a gap transport layer 4 and a current supply conductive layer 6, wherein said void transport layer 4 is disposed between said perovskite layer 3 and said current supply layer 6, said void transport layer comprising a compound selected from the compounds of the invention.  In the solar cells of the invention, the HTM 4 layer, which comprises the compounds of the invention, preferably has a thickness of 50-400 nm, preferably 100-200 nm, even more preferably 110-190 nm or 120-180 nm, and most preferably 100-170 nm, for example, about 150 nm.  Interestingly, in the devices of the present invention, the HTM layer may have a smaller thickness than the devices published in the state of the art, in which another HTM is used.  The advantage of using a thin layer of HTM is, first of all, to use less material and, in 45 NNNR11R12R13R14R15R11R12R13R14R15R11R12R13R14R15   secondly, to create a balance between the series resistance and the resistance in derivation.  The new HTM of the invention advantageously allows to select a relatively low thickness, while still avoiding short circuits.  In one embodiment, the HTM layer of the device of the invention, in particular, of the solar cell, for example, as shown in Fig.  7 or 8, comprises less than 20% of a dopant, wherein said 5 percentage represents the molar ratio of the doping compounds with respect to said HTM compound (mol / mol).  Surprisingly, the presence of conventional dopants commonly used with Spiro-OMeTAD did not have a significant impact on the performance of the devices of the invention containing the new compounds of the invention.  In a preferred embodiment, the HTM layer of the device of the invention comprises less than 15%, less than 10%, less than 5%, less than 3%, less than 1% of a dopant 10 (mol / mol) or is Dopant free.  The fact that dopants are neither necessary nor mandatory represents an important advantage.  First, fewer components are needed for the manufacture of the device, which also reduces the number of stages for the manufacture of the device.  Secondly, the addition of dopants makes them hygroscopic and causes defects, which will lead to a reduction in long-term efficacy.  In one embodiment, said doping compound, which is preferably absent or preferably presented in molar proportions as indicated above is lithium bis-trifluoromethylsulfonyl) imide (LiTFSI).  In a more preferred embodiment, the LiTFSI taken together with the additive tert-butylpyridine (t-BP), is absent or present, independently, at the molar proportions indicated above.  For example, in the HTM layer of the device, the combined molar concentration of t-BP and LiTFSI is less than 20% of the molar concentration of the new HTM compounds of the invention.  In particular, in the devices based on the illustrative compound HPDI, the presence of dopants, in particular, of LiTFSI combined with the t-BP additive, had a negative influence on the energy conversion efficiency () of the devices.  Other dopants that are frequently used in HTM are FK 209: tris- (bis (trifluoromethylsulfonyl) imide) tris (2- (1 H -pyrazol-1-yl) -4-tert-butylpyridine) cobalt (III)); H-TFSI: hydrogen bis (trifluoromethanesulfonyl) imide; FK269: tris (bis (trifluoromethylsulfonyl) -imide) of bis (2,6-di (1 H -pyrazol-1-yl) pyridin) cobalt (III); FK102: tris (1- (pyridin-2-yl) -1H-pyrazole) cobalt (III) tris- (hexafluorophosphate); and F4TCNQ: perfluoro-tetraciano-quinodimetano.   Another additive that can be used in HTMs is 2,6-dimethylpyridine.  Surprisingly, the presence of other dopants or LiTFSI with the additive t-BP in combination with 30 other dopants in the HTM did not lead to an improvement in the PV properties.  Therefore, in a preferred embodiment, all the dopants present in the HTM, in particular, the dopants and other dopants specified above, are present at a molar concentration of 20% molar, preferably ≤ 15% molar and most preferably 10% molar  In the method of preparing a solar cell according to the invention, the HTM layer can be applied by one of the methods selected from the group of: centrifugal coating, immersion coating, spray coating, sublimation, printing, coating by nozzle applicator or any other coating technique.  The organic-inorganic perovskite layer 3 is preferably provided between the semiconductor layer of type n 2 and the hole transport layer 4.  In the absence of an optional blocking layer, the perovskite layer 3 is preferably in direct contact with the semiconductor layer of type n 2 on one side and with the hollow transport layer 4 on the other side.  In principle, any organic-inorganic perovskite suitable for layer 4 can be used.  Such organic-inorganic perovskites that are useful for solar cells have been disclosed in the literature.   Preferred organic-inorganic perovskites are disclosed, for example, in international application 45 WO 2014/020499, filed on July 24, 2013.  The organic-inorganic perovskites disclosed in said application are expressly incorporated herein by reference.  More specifically, organic-inorganic perovskite can be selected, for example, from the compounds disclosed on page 10, line 30, to page 17, line 21.  Such disclosure is expressly incorporated herein by reference.  50 In addition, organic-inorganic perovskites can be selected from those disclosed in international application WO 2013/171517, filed on May 20, 2013, which discloses, in particular, mixed anion perovskites, which can also be used for the purposes of the present invention, in particular, as described on page 8, in the paragraph beginning with "the term 'perovskita' as defined herein [. . . ] "on page 19, including the first paragraph on page 19.  Such disclosure is expressly incorporated herein by reference.  According to a preferred embodiment, said organic-inorganic perovskite comprises a perovskite structure selected from any of the following formulas (XX) to (XXV): APbX3 (XX) 60 ASnX3 (XXI) A2PbX4 (XXII) A2SnX4 (XXIII) BPbX4 (XXIV) BSnX4 (XXV) 65    in which: A is an organic monovalent cation selected from organic primary, secondary, tertiary or quaternary ammonium compounds, including hetero rings or ring systems containing N, having A from 1 to 15 carbons and from 1 to 10 heteroatoms.  B is an organic bivalent cation selected from primary, secondary, tertiary or organic quaternary ammonium compounds having 1 to 15 carbons and 2 to 10 heteroatoms, and having two positively charged nitrogen atoms.  the three or four Xs are independently selected from Cl-, Br-, I-, NCS-, CN- and NCO-, preferably between Br- and I-.  In one embodiment, the organic-inorganic perovskite is exempt from Pb.  Therefore, in some embodiments, the metal atom is different from Pb.  Metal atoms can be Sn, as shown in formulas (XXI), (XXIII) and (XXV), but other metals can also be used to replace Sn.  For example, the Pb of the formulas (XX), (XXII) and (XXIV) can be replaced by any one or more selected from Cu2 +, Ni2 +, Co2 +, Fe2 +, Mn2 +, Cr2 +, Pd2 +, Zn2 +, Cd2 +, Ge2 +, Sn2 +, Pb2 +, Eu2 + and Yb2 +.  Preferably, A, in particular in any one of formulas (XX) to (XXIII), is a monovalent cation selected from any one of the compounds of the following formulas (1) to (8): 20 (1) (2 ) (3) (4) (5) (6) (7) (8) 25 in which: any one of R30, R31, R32 and R33, whenever present, is independently selected from aliphatic substituents C1 to C15 and aromatic C4 to C15, in which any one, several or all of the hydrogens of said substituent may be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from C1 to C8 aliphatic and C4 to C8 aromatic substituents, in which any one, several or all hydrogens of said substituent may be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from aliphatic substituents C1 to C4, preferably C1 to C3 and most preferably C1 to C2, in the that any one, several or all of the hydrogens of said substituent may be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from C1 to C8 alkyl, C2 to C8 alkenyl and C2 to C8 alkynyl, wherein said alkyl , alkenyl and alkynyl, if they comprise 3 or more carbons, can be linear, branched or cyclic, and in which several or all of the hydrogens of said substituent can be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from C1 to C6 alkyl, C2 to C6 alkenyl and C2 to C6 alkynyl, wherein said alkyl, alkenyl and alkynyl, if they comprise 3 or more carbons, can be linear, branched or cyclic, and in which several or all of the hydrogens of said substituent can be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from C1 to C4 alkyl, C2 to C4 alkenyl and C2 to C4 alkynyl, wherein said alkyl, alkenyl and alkynyl, if they comprise 3 or more carbons, can be linear, branched or cyclic, and in which several or all of the hydrogens of said substituent can be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from C1 to C3 alkyl, preferably C1 to C2, C2 to C3 alkenyl, preferably C2 and alkynyl C2 to C3, preferably C2, in which said alkyl, alkenyl and alkynyl, if they comprise 3 or more carbons, can be linear, branched or cyclic, and in which several or all of the R30NH3 + R31R30NH2 + R30R32R31NH + R30R33R32R31N + R30NH2 + R31R30NH + R30R32R31N + R30R31N +   hydrogens of said substituent may be replaced by halogen.  According to one embodiment, any one of R30, R31, R32 and R33, whenever present, is independently selected from C1 to C4 alkyl, more preferably C1 to C3 and even more preferably C1 to C2.  Most preferably, any one of R30, R31, R32 and R33 is methyl.  Again, said alkyl may be completely or partially halogenated.  5 With respect to B, reference is taken, for example, to document WO 2014/020499, specifically, from page 12, line 22, to page 14, line 31, in which the substituents R1, R2, R3 and R4 of WO 2014/020499 are as defined from page 14, line 27, to page 16, line 8.  Preferably, R1, R2, R3 and R4 of WO 2014/020499 are selected from the substituents R30, R31, R32 and R33, provided that they are present, as defined above, also in the context of the bivalent cation B.  Said disclosure is expressly incorporated herein by reference.  The organic-inorganic perovskite layer can be deposited by various techniques, for example, as disclosed in the international patent application PCT / EP2014 / 05912, which claims the priority of EP13166720. 6.  In particular, by sequential deposition (J.  Burschka, N.  Pellet, S. -J.  Moon, R.  Humphry-Baker, P.  Gao, M.  K.  Nazeeruddin, M.  Grätzel  Nature 2013, 499, 316).  According to one embodiment, the solar cell of the invention comprises a structure and / or surface augmentation layer.  Figure 8 illustrates a solar cell comprising a surface augmentation structure 9.  The remaining reference numbers are described the same as with respect to Fig.  7.  According to a preferred embodiment, the surface augmentation structure comprises or consists essentially of one selected from the group of: a semiconductor material and an insulating material.  If the surface augmentation structure comprises a semiconductor material, it is preferably a n-type semiconductor material.  Traditionally, the surface augmentation structure is manufactured from n-type semiconductor nanoparticles such as TiO2 nanoparticles.  Surface augmentation structures made of non-conductive materials have also been disclosed.  For example, the surface augmentation structure can be manufactured with an insulating material.  In this case, the absorber 3, for example, the organic-inorganic perovskite layer 3, which is deposited on the surface augmentation structure 9, is also in contact with a semiconductor layer of type n 2.  In this case, the surface increase structure 9, which is deposited on the semiconductor layer of type n 2, does not continuously cover said semiconductor layer of type n 2, so that the absorber 3 can also come into contact with the semiconductor layer of type n 2.  For example, the semiconductor layer 30 of type n 2 may comprise a layer of dense n type nanoparticles (also known as "compact"), and the surface augmentation structure 9 is prepared from nanoparticles of the same semiconductor material of type n than layer 2.  The surface augmentation structure is preferably nanoscale structured.  The structures of said surface augmentation structure increase the effective surface compared to the surface of the solar cell.  Preferably, the surface augmentation structure is mesoporous.  The surface augmentation structure is also known as "scaffold structure" or "surface-increasing scaffold", for example.  According to one embodiment, the surface augmentation structure of the solar cell of the invention comprises and / or consists of nanoparticles.  The term "nanoparticles" encompasses particles or particulate elements 40 which may have any shape, in particular, also referred to, for example, nanollamines, nanocolumns and / or nanotubes.  Etgar et al. , Adv.  Mater.  2012, 24, 2202-2206, for example, report on anatase TiO2 nanollamines.  Preferably, the nanoparticles comprise or consist essentially of said semiconductor material.  The nanoparticles preferably have average dimensions and / or sizes in the range of 2 to 300 nm, preferably 3 to 200 nm, even more preferably 4 to 150 nm, and most preferably 5 to 100 nm.  "Dimension" or "size" with respect to the nanoparticles means in this document extensions in any direction of space, preferably, the maximum average extent of the nanoparticles.  In the case of substantially spherical or elliptical particles, reference is preferably made to the average diameter.  In the case of nanolilamines, the dimensions indicated refer to length and thickness.  Preferably, the size of the nanoparticles is determined by transmission electron microscopy (TEM) and restricted area electron diffraction (SAED) as disclosed by Etgar et al. , Adv.  Mater.  2012, 24, 2202-2206.  According to one embodiment, the surface augmentation structure comprises, consists essentially of or consists of one or more selected from the group consisting of Si and metal oxide, including transition metal oxides.   For example, the surface augmentation structure comprises a material selected from SiO2, TiO2, Al2O3, ZrO2, HfO2, SnO2, Fe2O3, ZnO, WO3, Nb2O5, In2O3, Bi2O3, Y2O3, Pr2O3, CeO2 and other metal oxides of Rare earths CdS, ZnS, PbS, Bi2S3, CdSe, CdTe, MgTiO3, SrTiO3, BaTiO3, Al2TiO5, Bi4Ti3O12 and other titanates, CaSnO3, SrSnO3, BaSnO3, Bi2Sn3O9, Zn2r3O3, Zn2r3O3, CaNZr3, S3O3O3 other zirconatos, combinations of two or more of the 60 oxides mentioned above and of other oxides of multiple elements containing at least two of the elements of alkali metals or alkaline earth metals Al, Ga, In, Si, Ge, Sn, Pb, Sb , Bi, Sc, Y, La or any other lanthanide, Ti, Zr, Hf, Nb, Ta, Mo, W, Ni or Cu.  According to a preferred embodiment, the surface augmentation structure comprises one or more among, for example, TiO2, Al2O3, SnO2, ZnO, Nb2O5 and SrTiO3.  According to one embodiment, said surface augmentation structure forms a continuous layer.   and / or complete or, alternatively, a discontinuous and / or incomplete layer.  According to one embodiment, said surface augmentation structure forms a layer having a total thickness of 10 to 3000 nm, preferably 12 to 2000 nm, preferably 15 to 1000 nm, more preferably 20 to 500 nm, even more preferably from 50 to 400 nm and most preferably from 100 to 300 nm.  For the purposes of the present specification, a "continuous layer" or a "complete layer" is a layer that completely covers an adjacent layer, such as the conductive support layer, so that there may be no physical contact between the two layers separated by the continuous or complete layer and adjacent to said continuous or complete layer.  For example, one, two or all of those selected from the group consisting of the perovskite layer, the n-type semiconductor layer and the hollow transport layer are preferably continuous layers.  Preferably, the underlying layer, if present, is also a complete layer.  The current collector and / or the conductive support are also preferably continuous layers.  If the surface augmentation structure is provided in a discontinuous and / or incomplete manner on said conductive support layer, the perovskite layer is or could be in direct contact with said current collector and / or underlying layer.  The surface augmentation structure can be prepared by screen printing, centrifugal coating, nozzle applicator coating, blade coating, immersion coating or meniscus coating, or physical vapor deposition process, for example, as conventional for the preparation of porous semiconductor surfaces (for example, TiO2) in heterojunction solar cells, see, for example, Noh et al. , Nano Lett.  2013, 7, 486-491 or Etgar et al. , Adv.  Mater.  2012, 24, 2202-2206.  The preparation of nanoporous semiconductor structures and surfaces has been disclosed, for example, in EP 0333641 and EP 0606453.  If the surface augmentation structure is made of a semiconductor material of type n, the electrode and / or the working photonode of the solar cell of the invention is the assembly of the light collecting perovskite and the semiconductor material of increasing the surface.  In other embodiments, the surface augmentation structure as defined above is absent.  The type n 2 semiconductor layer can be manufactured from the type n semiconductor materials listed above with respect to the surface augmentation structure 9.  Instead of the metal oxides mentioned above, semiconductor polymers of type n can be used, for example, in particular, polymer-based solar cells.  This possibility applies, in particular, if there is no structure for increasing the surface area made of metal oxide nanoparticles.  Accordingly, layer 2 of Fig.  7 can be, for example, a layer of organic material of type n as electron transport material (ETM).  ETMs can be selected from a wide variety of conductive materials for load pickup.  Illustrative organic ETMs are fullerene and PCBM (C61 phenylbutyric acid methyl ester).  According to one embodiment, the solar cell of the invention preferably comprises a current collector 35.  The current collector preferably forms a continuous layer and is preferably adapted to capture the current (and / or electrons) generated by the solar cell and transport it to an external circuit.  The current collector preferably provides the electric front contact of the solar cell.  The current collector preferably comprises a conductive or semiconductor material, such as an organic or inorganic conductive material, such as, for example, a metal, a doped metal, a conductive metal oxide or a doped metal oxide.  In a preferred embodiment, the current collector comprises a transparent conductive oxide (TCO).  In some preferred embodiments, the current collector comprises a material selected from indium doped tin oxide (ITO), fluorine doped tin oxide (FTO), ZnO-Ga2O3, ZnO-Al2O3, tin oxide, doped tin oxide with antimony (ATO), SrGeO3 and zinc oxide, or combinations thereof.  The current collector is preferably arranged to capture and conduct the current generated in the working electrode or photo anode.  Therefore, the current collector is preferably in electrical contact with the working electrode or photo anode.  Preferably, the current collector 5 is in direct contact with the semiconductor layer of type n 2.  According to one embodiment, the solar cell of the invention preferably comprises one or more 50 support layers.  The support layer preferably provides the physical support of the device.  Furthermore, the support layer preferably provides protection with respect to physical damage and, therefore, delimits the solar cell with respect to the outside, for example, on at least one of the two main sides of the solar cell.  The support layer is not specifically shown in the figures.  In some embodiments, glass or plastic coated with a TCO current collector is used.  These materials, which are available in the market, contain the support as well as the current collector.  For example, layer 5 of Fig.  7 and 8 can be considered a glass or a plastic coated with TCO, in which the TCO faces layer 2 and the glass or plastic faces the outside of the cell and provides the surface or the outer side 7.  As shown in Fig.  7 and 8, the solar cell of the invention preferably comprises a conductive layer providing current and / or electrons 6.  Said layer can also be considered as the counter electrode, which preferably comprises a material that is suitable for providing electrons and / or filling the gaps into the device.  In particular, layer 6 is preferably provided on the HTM layer and injects electrons into the holes that have moved from the perovskite layer 3 through the HTM layer 3.  The layer 6 is preferably connected to the external circuit, for example, thus providing the electrical back-contact of the solar cell that is required to provide the electrons that were removed during operation of the solar cell in the current collecting layer 7.  In this regard, the solar cell of the invention is preferably a regenerating device.  The conductive current supply layer   and / or electrons 6 may comprise, for example, one or more materials selected from (the group consisting of) Pt, Au, Ni, Cu, Ag, In, Ru, Pd, Rh, Ir, Os, C, MoO, including carbon nanotubes, graphene and graphene oxide, and a combination of two or more of the aforementioned.  The conductive current or electron supply layer can be applied on the hole transport layer in a conventional manner, for example, by thermal or electron beam evaporation, ionic spraying, printing (inkjet printing or screen printing) or process spray, optionally dispersed or dissolved in a solvent-based carrier medium.  The counter electrode application process preferably depends on the material selected.  If an organic material is selected for the counter electrode, such as a carbon-based electrode, it can be deposited by inkjet printing or screen printing.  Metals such as Ag or Cu can be deposited as a paste.  The solar cell of the invention may comprise additional layers such as blocking layers, additional perovskite layers, support layers, etc., as is known in the art.  Appropriate coating techniques with respect to different layers of the device of the invention have been disclosed.  It should be noted that the deposition of the layers can be initiated from either side, that is, from the anode or cathode electrode.  When the device comprises a structure for increasing the mesoscopic surface, the preparation can be initiated with the deposition of the semiconductor layer of type n on the current collector, since the structure for increasing the nanoporous surface based on metal oxide generally requires Sintering  Components that are more sensitive to heat are therefore deposited in later stages.  In inverted devices, deposition generally begins from the cathode side, with the deposition of the HTM 4 layer on the conductive electron supply layer 6 20 (Fig.  7), followed by the deposition of the perovskite layer 3 and a semiconductor layer of type n 2, before applying the current collecting layer 5.  In a preferred embodiment, the synthesis of the compounds of the invention begins based on the basic structure of triazatruxen that can be purchased on the market (No. 1 in Fig.  1), in which the hydrogens are substituted according to the exact compound of the invention to be obtained.  Preferably, the hydrogen atoms of the nitrogen atoms are first substituted, to provide R1 substituents.  Second, in an optional step, the hydrogen atoms of the carbon atoms can be substituted to provide optional R2-R5 substituents other than hydrogen.  In a preferred embodiment, the hydrogen of R3 is substituted, leaving R2, R4 and R5 as hydrogens.  In one embodiment, the substituents R1 are introduced to increase the solubility of the compounds, and the substituents R2-R5 introduced are selected to adjust the redox potential of the compound in order to adjust the level of energy needed.  If such adjustment is not necessary, R2-R5 are preferably hydrogen.  The present invention will now be illustrated by way of example.  These examples do not limit the scope of the present invention, which is defined by the appended claims.   35 Examples: 1.  Synthesis of the illustrative compounds according to the embodiments of the invention 1. 1 Materials and methods 40 All reagents from commercial sources were used without further purification, unless otherwise indicated, and the reactions were carried out under dry N2.  All dry reactions were performed with glass material that was flamed under high vacuum and refilled with N2.  All extracts were dried over powdered MgSO4 and the solvents were removed by evaporation on a rotary evaporator under reduced pressure.  Flash chromatography was performed using Silicycle UltraPure SilicaFlash P60, 40-63 m (230-400 mesh).  NMR spectra 45 (nuclear magnetic resonance) of 1H (proton) and 13C (carbon 13) were recorded, and are shown in ppm using solvent as internal standard: Deuterium chloroform (CDCl3) at 7.24 ppm and 77.23 ppm for 1H and 13C, respectively; C6D6 deuterium benzene at 7.16 ppm and 128.39 ppm for 1H and 13C, respectively; dimethylsulfoxide-d6 at 2.50 ppm and 39.51 ppm for 1H and 13C, respectively.   50 1. 2 Basic starting material 10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c] carbazole (1) A mixture of 2-indolinone (10 g, 75 mmol) and POCl3 was heated (50 ml) at 100 ° C for 8 h.  Then, the reaction mixture was poured on ice and carefully neutralized with NaOH.  After neutralization, the precipitate was filtered, giving the crude product as a brown solid.  The crude product was passed through a bed of thick silica gel and recrystallized from acetone, resulting in a pure pale yellow solid having a mass of 3.5 g.  The yield obtained was 14%.  1H NMR (400 MHz, DMSO-d6): 11.88 (s, 3H), 8.68 (dd, J = 7.7; 1.4 Hz, 3H), 7.73 (dt, J = 7 , 9; 1.0 Hz, 3H), 7. 36 (dtd, J = 22.3; 7.2; 1.2 Hz, 6H).  The basic structure of triazatruxene (1) was used in other experiments as a starting material for the synthesis of additional intermediates (2), (3) and / or compounds of the invention HPDI and HMDI according to the scheme shown in the Figure 1.   one. 3 5,10,15-Trihexil-10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole (2) To a solution of (1) (400 mg, 1, 2 mmol, 1 eq. ) in DMF (10 ml), NaH (0.1 g, 4.1 mmol, 3.5 eq) was added at room temperature and stirred for half an hour, then 1-bromohexane (0.76 g, 4 , 63 mmol, 65   4 eq) with a syringe and then the mixture was refluxed for 2 h.  The cooled mixture was poured into water and extracted with DCM.  The organic phase was dried over MgSO4.  The product was isolated by isolation on a silica gel column with 20% DCM in hexane, giving a product as a pale yellow solid having a mass of 450 mg.  The yield obtained was 92%.  1H NMR (400 MHz, CDCl3-d): 8.32 (d, J = 8.0 Hz, 3H), 7.70-7.63 (m, 3H), 7.55-7.44 (m , 3H), 7.37 (m, 3H), 4.99-4.90 (m, 5 6H), 2.02 (m, 6H), 1.41 - 1.28 (m, 18H), 0 , 84 (t, J = 7.0 Hz, 9H).   one. 4 3,8,13-Tribromo-5,10,15-trihexyl-10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole (3) To a solution of ( 2) (350 mg, 0.58 mmol, 1 eq. ) in 30 ml of CHCl3, NBS (310 mg, 1.75 mmol, 3 eq. ) in 5 ml of DMF drop by drop with a syringe at 0 ° C.  After the addition, the reaction mixture 10 was stirred for 1 h at room temperature.  The mixture was extracted with DCM and the organic phase was dried over MgSO4.  The product was isolated by isolation on a silica gel column with 10% DCM in hexane, giving a product as a pale yellow solid having a mass of 400 mg.  The yield obtained was 82%.  1H NMR (400 MHz, CDCl3-d): 8.05 (d, J = 8.0 Hz, 3H), 7.71 (s, 3H), 7.55 (d, J = 8.0 Hz, 3H), 4.99-4.90 (m, 6H), 2.02 (m, 6H), 1.41-1.28 (m, 18H), 0.84 (t, J = 7.0 Hz , 9H).  15 1. 5 5,10,15-Trihexyl-3,8,13-trimethoxy-10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole (HMDI) In a flask of three 50 ml mouths, a solution of 1.95 ml (10.5 mmol, 15 eq. ) 5.4 M sodium methoxide in methanol, dry DMF (15 ml), copper (I) iodide (810 mg, 4.3 mmol, 6 eq. ) (3) (0.6 g, 0.72 mmol, 1 eq. ) for 3 h under an atmosphere of N2.  After that, the solution was filtered while it was hot through celite, removing the copper iodide (I) and washed with water.  The mixture was extracted with DCM and the organic phase was dried over MgSO4.  The product was isolated by isolation on a silica gel column with 50% DCM in hexane, giving a product as a pale yellow solid having a mass of 300 mg.  The yield obtained was 55%.  1H NMR (400 MHz, CDCl3-d): 8.05 (d, J = 8.0 Hz, 3H), 7.71 (s, 3H), 7.55 (d, J = 8.0 Hz, 3H), 4.95 (s, 6H), 4.03 (s, 9H), 2.02 (m, 6H), 1.41 - 1.28 (m, 18H), 0.84 (t, J = 7.0 Hz, 25 9H); and 13 C NMR (100 MHz, Benzene-d6): δ 157.31; 143.12; 138.04; 122.55; 118.14; 107.27; 104.20; 95.97; 55.02; 46.71; 31.23; 29.28; 26.23; 22.35; 13.71.  C45H57N3O3 [M +] Exact mass = 687.44, MS (mass spectrometry) (ESI) (electrospray ionization) = 687.46.   one. 6 1- (Hexyloxy) -4-iodobenzene (4) 30 P-iodophenol (2 g, 9 mmol, 1 eq. ), 1-bromohexane (2.25 g, 13.5 mmol, 1.5 eq. ), K2CO3 (2.5 g, 18 mmol, 2 eq. ) and DMF (20 ml) in a 100 ml flask of a mouth equipped with a reflux condenser and a magnetic stir bar.  The mixture was refluxed overnight, cooled and poured into water, after which it was neutralized by NaOH.  The resulting mixture was extracted with DCM.  The organic mixture was dried over anhydrous MgSO4.  After filtration, the solvent was removed by evaporation in a rotary evaporator.  The residue was purified by column chromatography using hexane as eluent, to provide a compound as a clear oil having a mass of 2.5 g.  The yield obtained was 75%.  1H NMR (400 MHz, CDCl3-d): 7.56-7.54 (d, J = 9.00 Hz, 2H), 6.69-6.67 (d, J = 9.00 Hz, 2H ), 3.93-3.91 (t, J = 6.50 Hz, 2H), 1.79-1.76 (m, 2H), 1.47-1.44 (m, 2H), 1, 38-1.36 (m, 4H), 0.92-0.90 (t, J = 7.00 Hz, 3H).  40 1. 7 5,10,15-Tris (4- (hexyloxy) phenyl) -10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole (HPDI) To a solution of ( 1) (250 mg, 0.74 mmol, 1 eq. ), (4) (0.9 g, 3 mmol, 4 eq. ) in 5 ml of quinoline, CuI (550 mg, 2.9 mmol, 4 eq. ) and K2CO3 (400 mg, 2.9 mmol, 4 eq. ).  After stirring at 190 ° C overnight under a N2 atmosphere, the reaction mixture was allowed to cool to room temperature and subsequently diluted with DCM, after which it was filtered through a short bed of celite.  The filtrate was concentrated in vacuo.  The residue was purified by column chromatography eluting with 30% DCM in hexane, giving 170 mg of the pale yellow solid.  The yield obtained was 55%.  1H NMR (400 MHz, CDCl3-d): 7.59 (d, J = 6.8 Hz, 6H), 7.30 (d, J = 8.3 Hz, 6H), 7.13-7, 25 (m, 6H), 6.85 (t, J = 8.0 Hz, 3H), 6.21 (d, J = 8.1 Hz, 3H), 4.14 (t, J = 5.9 Hz, 6H), 2.13-1.83 (m, 6H), 1.44 (t, J = 57.8 Hz, 18H), 0.98 (s, 9H); and 50 13C NMR (100 MHz, C6D6-d6): 159.06; 142.55; 138.43; 133.86; 130.08; 127.57; 123.18; 123.07; 120.23; 115.53; 110.28; 104.58; 68.04; 31.58; 29.15; 25.72; 22.67; 13.94, C60H63N3O3 [M +] Exact mass = 873.4869, MS (MALDI-TOF) (desorption and laser ionization assisted by matrix-flight time) = 873.1144.   2.  Manufacture of solar cells according to the invention 55 2. 1 Materials and methods CH3NH3I was synthesized by preparing an equimolar solution of methylamine (40% in water) and HI (iodide) (57% in water) in an ice bath to control the temperature.   60 2. 2 Device manufacturing The FTO coated glass was laser etched.  The substrates were cleaned with Hellmanex, and rinsed with deionized water and ethanol.  After that, the samples were subjected to ultrasound in 2-propanol and dried with compressed air.  Before deposition of the compact layer, the substrates were treated with UV / O3 to remove organic residues.  65 A layer of blocking TiO2 was deposited by spray pyrolysis using a solution of titanium diisopropoxide bis (acetyl acetonate) (1 ml of titanium diisopropoxide bis (acetyl acetone))   commercial) 75% in 2-propanol in 19 ml of pure ethanol) using O2 as carrier gas.  During said process, the recorded substrates were heated to 450 ° C to facilitate anatase formation.  After cooling again, the substrates were immersed in 20 mM aqueous solution of TiCl4 and baked for 30 minutes at 70 ° C.  The samples were then washed with deionized water and heated at 500 ° C for 30 minutes.  After cooling again, the substrates were cut into the appropriate cell size.  5 The mesoporous layer of TiO2 (mp-TiO2) was prepared by centrifugation coating of 35 l per cell of a solution prepared with 1 g of 30NR-D in 3.5 g of absolute ethanol.  The centrifugal coating conditions used were: speed = 4. 000 rpm; acceleration = 2. 000 rpm · s-1; time = 30 s.  Subsequently, the samples were sequentially sintered: 125 ° C for 5 min, 325 ° C for 5 min, 375 ° C for 5 min, 450 ° C for 15 min and 500 ° C for 15 min.  10 The PbI2 film was deposited using a double coating of PbI2 solution, and kept concentrated at 1.25 M in DMF at 70 ° C to avoid any precipitation.  50 µl of said solution was deposited and used for centrifugal coating on the mesoporous TiO2 film.  Then, said films were tempered at 70 ° C for 30 minutes.  After cooling again, the centrifugal coating process was repeated using the same centrifugal coating parameters.  During said process, a partial dilution of the first PbI2 film was observed.  The tempering stage was also repeated.  100 µl of CH3NH3I solution (8 mg · ml-1) was spread on the PbI2 film, forming perovskite after 20-25 s, being able to observe the conversion of PbI2 to CH3NH3PbI3 (from yellow to black).  Finally, the excess solvent was removed by centrifugal coating and additionally frightened at 70 ° C for 30 minutes.  The hollow transport materials (HTM) were coated by centrifugation, either 5,10,15-trihexyl-3,8,13-trimethoxy-10,15-dihydro-5H-diindolo [3,2-a: 3 ' , 2'-c] carbazole (HMDI) or 5,10,15-tris (4- (hexyloxy) phenyl) -10,15-dihydro-5H-diindole [3,2-a: 3 ', 2'-c ] carbazole (HPDI), depending on the device, (speed = 2. 000 rpm, acceleration = 1. 000 rpm · s-1, time = 30 s).  The HMDI solution was found to be 0.04241 M, and 0.03338 M HPDI was obtained in chlorobenzene.  25 In some illustrative devices, dopant solutions with additives were also included.   In some devices, the LiTFSI dopant and the t-BP additive were added to the HMDI.  In these devices, LiTFSI and t-BP were added at the following concentrations expressed in molar percentage with respect to HMDI: LiTFSI: 25.5% molar; and additives: t-BP: 141 mol%.  In some devices containing HMDI, tris- (bis (trifluoromethylsulfonyl) imide) dopant of 30 tris (2- (1H-pyrazol-1-yl) -4-tert-butylpyridine) cobalt (III)) (FK 209) was added together with the dopant LiTFSI and the additive t-BP.  In these devices, the dopants and additives were presented at the following concentrations expressed in molar percentage with respect to HMDI, dopants: FK 209: 13.3% molar; LiTFSI: 25.5% molar; and additives: t-BP: 141 mol%.   In devices containing HPDI, dopants were used at the following concentration, if present: LiTFSI: 32% molar; and the additives were used at the following concentration, if present: t-BP: 179 molar% (both with respect to the molar amount of HPDI).  An 80 nm thick gold composite cathode was used and deposited by thermal evaporation.   2. 3 Characterization of the devices 40 The J-V curves were calculated using an MA (air mass) of 1.5 G as the source.  For the IPCE measurements, an electrical source, a 300 W Xe lamp with a power source, was used, and connected to a monochromator.  The results are shown in Table 1 below: Table 1: PV performance of the solar cells of the invention 45 Configuration Jsc (mA / cm2) Vca (V) FF (%) FTO / bl-TiO2 / mp- TiO2 / CH3NH3PbI3 / HMDI / Au 14.43 0.938 0.637 8.62 FTO / bl-TiO2 / mp-TiO2 / CH3NH3PbI3 / HMDI + tBP + LiTFSI / Au 13.70 0.868 0.715 8.50 FTO / bl-TiO2 / mp- TiO2 / CH3NH3PbI3 / HMDI + tBP + LiTFSI + FK209 / Au 16.63 0.810 0.613 8.26 FTO / bl-TiO2 / mp-TiO2 / CH3NH3PbI3 / HPDI / Au 17.96 0.894 0.642 10.30 FTO / bl-TiO2 / mp-TiO2 / CH3NH3PbI3 / HPDI + tBP + LiTFSI / Au 9.97 0.901 0.650 5.84 FF: Filling factor; : energy efficiency 50   In various devices prepared, energy conversion efficiencies of 8-10% were usually achieved.  A certain cell reached an efficiency close to 11% (not shown in Table 1).  In several devices, particularly those based on HPDI, doping had a negative impact on performance, and in those based on HMDI, doping and non-doping had a similar impact on performance.  In general, doping using LiTFSI and t-BP did not improve the PV properties.  5 In Figures 2 and 3, the more detailed performance of the devices of the invention is shown.  The cyclic voltamperograms and UV-Vis absorption spectra shown in Figures 4 and 5 show the characterization of the compounds.  Both compounds absorb in the UV region between 252-350 nm.  The thermogravimetric analysis (TGA) curves of the HMDI and HPDI compound as shown in Figure 6 of the invention are stable at temperatures of 350 ° C for HPDI and 400 ° C for HMDI.  In general, the compounds of the invention are stable at temperatures of 300 ° C or higher, preferably 350 ° C or higher.    
    权利要求:
    Claims (1)
    [1]
    Claims 1. A compound comprising the following structure of formula (I): (I) wherein R1 is selected from substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl, and wherein R2-R5 are selected, from independently, between H, and substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl and substituents of the following formulas (II), (III) and (IV): (II) (III) (IV) in which A is selected from O, S, Se, or other electron donor element, and R1, R2, and R3, whenever present, are independently selected from alkyl, alkenyl, alkynyl, aryl; wherein any one of said alkyl, alkenyl and alkynyl can be linear, branched or cyclic. 2. The compound of claim 1, wherein R1 is selected from alkyl and substituted aryl, wherein the substituents on said aryl are selected from alkyl and from substituents of formulas (II), (III) or (IV) , and wherein R2-R5 are independently selected from H, alkyl and substituents of formulas (II), (III) or (IV). 3. The compound of claims 1 or 2, wherein R1 is selected from alkyl and substituted phenyl, wherein the substituents on said phenyl are independently selected from alkyl and alkoxy, and R2-R5 is independently selected from H, alkyl and alkoxy. The compound of any one of the preceding claims, which is a compound of formula (V): (V) R1R1R1NNNR5R4R3R2R2R3R4R5R2R3R4R5AR1R2NR1R3R2SiR1R1R1R1NNNR3R3R3 wherein R1 is as defined in any one of claims 1-3 and wherein R3 is defined as R2-R5 in any one of claims 1-3, respectively. 5. The compound of any one of the preceding claims, which is selected from a compound of the following formulas (VI) or (VII): (VI) (VII) in which R6 and R7 are independently selected, between linear, branched or cyclic C1-C12 alkyls. The compounds of claim 5, wherein R6 is selected from linear and branched C4-C10 alkyls, and R7 is selected from linear and branched C1-C10 alkyls. 7. The compound of any one of the preceding claims, which is soluble in any one, in several or in all solvents selected from the group consisting of: chlorobenzene, benzene, 1,2-dichlorobenzene, toluene and chloroform to more than 50 mg of compound per ml of solvent at 25 ° C. The compound of claim 7, which is soluble in any one, in several or all of the solvents mentioned in claim 7 at more than 100 mg of compound per ml of solvent at 25 ° C. The compound of any one of the preceding claims, which is selected from 5,10,15-trihexyl-3,8,13-trimethoxy-10,15-dihydro-5H-diindolo [3,2-a: 3 ', 2'-c] carbazole and 5,10,15-tris (4- (hexyloxy) phenyl) -10,15-dihydro-5H-diindolo [3,2-a: 3', 2'-c] carbazole . 10. An optoelectronic device comprising the compound of any one of claims 1-9. The optoelectronic device of claim 10, which is a solar cell, preferably a solid state solar cell. The optoelectronic device of any one of claims 10-11, which is an organic-inorganic perovskite sensitized solar cell. The optoelectronic device (1) of any one of claims 10-12, comprising a current-collecting conductive layer (5), an n-type semiconductor layer (2), an organic-inorganic perovskite layer (3 ), a hole transport layer (4) and a current supply conductive layer (6), wherein said hole transport layer (4) is provided between said perovskite layer (3) and said current supply layer (6), said void transport layer comprising a void transport material comprising the compound of any one of claims 1-9. The optoelectronic device of any one of claims 10-13, wherein said gap transport layer has a thickness of 50-400 nm, preferably 100-200 nm, even more preferably 110-190 nm or 120-180 nm, and most preferably 130-170 nm or 135-165 nm, 140-160 nm, for example about 150 nm. 45 NNNOR6OR6OR6R6R6R6NNNOOOR7R7R7 15. Use of the compounds of any one of claims 1-9 as a gap transport material (HTM). 16. A production process of a solar cell (1) comprising the steps of applying a plurality of layers comprising an organic-inorganic perovskite layer (3), a void transport layer (4) and a conductive supply layer stream (6), wherein said gap transport layer (4) comprises an HTM comprising a compound selected from the compounds defined in any one of claims 1-9. 17. A process for the production of the compounds of any one of claims 1-9, comprising the steps of: (i) replacing the nitrogen atoms of a triazatruxene basic structure (1) with a substituent selected from alkyl, substituted or unsubstituted alkenyl, alkynyl and aryl (R1 of any one of claims 1-9); and, optionally, (ii) replacing one or more hydrogen atoms of the benzene rings of the triazatruxene basic structure (1) with substituents selected from the group consisting of: substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl and substituents of the following formulas (II), (III) and (IV), (II) (III) (IV), in which A is selected from O, S or Se, and R1, R2 and R3, provided that they are present, are independently selected from alkyl, alkenyl, alkynyl, aryl; wherein any one of said alkyl, alkenyl and alkynyl of step (i) or of step (ii) may be linear, branched or cyclic. The process of claim 17, wherein said step (ii) is carried out by halogenating one 25 or more hydrogen atoms of the benzene rings of the basic triazatruxene structure (1) and by substituting atoms of halogen with said substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl and substituents of formulas (II), (III) and (IV). AR1R2NR1R3R2SiR1
    类似技术:
    公开号 | 公开日 | 专利标题
    ES2575511B1|2017-04-05|New compound and its use as hollow transport material
    Ke et al.2018|Dopant-free tetrakis-triphenylamine hole transporting material for efficient tin-based perovskite solar cells
    Cho et al.2017|Indolo [3, 2-b] indole-based crystalline hole-transporting material for highly efficient perovskite solar cells
    EP3024042B1|2017-07-19|PEDOT in perovskite solar cells
    US9437825B2|2016-09-06|Hole-transporting material for inorganic/organic hybrid perovskite solar cells
    KR101823719B1|2018-01-30|Naphtalene monoimide derivatives and use thereof as photosensitizers in solar cells and photodetectors
    EP2883881A1|2015-06-17|Cobaltcomplex salts and mixtures of Cobaltcomplex salts for use in DSSC
    KR20160065926A|2016-06-09|Hole transport material
    Wang et al.2019|Defect Passivation by Amide-Based Hole-Transporting Interfacial Layer Enhanced Perovskite Grain Growth for Efficient p–i–n Perovskite Solar Cells
    KR20150123312A|2015-11-03|Novel compound and photoelectric conversion element using same
    Michaleviciute et al.2014|Star-shaped carbazole derivative based efficient solid-state dye sensitized solar cell
    Hu et al.2013|Rigid triarylamine-based D–A–π–A structural organic sensitizers for solar cells: the significant enhancement of open-circuit photovoltage with a long alkyl group
    WO2012011023A2|2012-01-26|Dye solar cell with improved stability
    KR101619780B1|2016-05-11|hole-transporting material for inorganic-organic hybrid perovskite solar cells
    KR101760492B1|2017-07-21|Novel compounds, method of preparation thereof and organic solar cell comprising the same
    US9054325B2|2015-06-09|Rylene monoimide derivatives and use thereof as photosensitizers in solar cells and photodetectors
    US20190334092A1|2019-10-31|Dispiro-oxepine/thiapine derivatives for optoelectronic semiconductors
    JP5004575B2|2012-08-22|Photosensitizer, semiconductor electrode and photoelectric conversion element using the same
    KR20140138783A|2014-12-04|Dye-sensitized photoelectric conversion element
    KR101465454B1|2014-12-02|Photosensitizer for photovoltaic cell, and photovoltaic cell including same
    KR101778292B1|2017-09-13|Triphenylene derivatives, method of preparation thereof and organic solar cell comprising the same
    US20220033342A1|2022-02-03|Hole transport material, synthesis thereof, and solar cell
    KR101760493B1|2017-07-21|Benzobisoxazole derivatives, method of preparation thereof and organic solar cell comprising the same
    KR20140134288A|2014-11-21|Rylene monoimide derivates and the use thereof as photosensitizers in solar cells and photodetectors
    KR20160141541A|2016-12-09|Hole transfer material, method for preparation thereof, and solar cell comprising the same
    同族专利:
    公开号 | 公开日
    ES2575511B1|2017-04-05|
    EP3225624A1|2017-10-04|
    US20180006241A1|2018-01-04|
    WO2016083655A1|2016-06-02|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2005077956A1|2004-02-16|2005-08-25|Ihara Chemical Industry Co., Ltd.|Substituted sym-triindole|CN106432251B|2016-10-09|2018-11-13|安徽科技学院|The starlike luminous organic material of six arms and its organic electroluminescence device|
    KR101776533B1|2016-11-03|2017-09-07|현대자동차주식회사|Preparing method for bonded type perovskite solar cell|
    EP3489240A1|2017-11-28|2019-05-29|Ecole Polytechnique Fédérale de Lausanne |In-situ cross-linkable hole transporting triazatruxene monomers for optoelectronic devicestr|
    CN108948026A|2018-06-15|2018-12-07|南京邮电大学|One kind three and carbazole-phenyl hole mobile material and the preparation method and application thereof|
    CN108794494A|2018-06-18|2018-11-13|南京邮电大学|One kind three and carbazole-aromatic amine derivant hole mobile material and the preparation method and application thereof|
    CN110698654B|2018-07-10|2021-04-02|中国科学院长春应用化学研究所|Hyperbranched conjugated polyelectrolyte based on trimeric indole, preparation method and application thereof|
    法律状态:
    2017-04-05| FG2A| Definitive protection|Ref document number: 2575511 Country of ref document: ES Kind code of ref document: B1 Effective date: 20170405 |
    2021-09-15| FD2A| Announcement of lapse in spain|Effective date: 20210915 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES201431776A|ES2575511B1|2014-11-28|2014-11-28|New compound and its use as hollow transport material|ES201431776A| ES2575511B1|2014-11-28|2014-11-28|New compound and its use as hollow transport material|
    EP15863556.5A| EP3225624A1|2014-11-28|2015-11-27|Novel compound and use thereof as a hole-transport material|
    US15/529,935| US20180006241A1|2014-11-28|2015-11-27|Novel compound and use thereof as a hole transport material|
    PCT/ES2015/070864| WO2016083655A1|2014-11-28|2015-11-27|Novel compound and use thereof as a hole-transport material|
    [返回顶部]